Information de reference pour ce titreAccession Number: | 01451458-199912000-00017.
|
Author: | Paterson, David L.; Yu, Victor L.
|
Institution: | Infectious Disease Section, Veterans Affairs Medical Center, Pittsburgh, Pennsylvania
|
Title: | |
Source: | Clinical Infectious Diseases. 29(6):1419-1422, December 1999.
|
References: | 1. Karas JA, Pillay DG, Muckart D, Sturm AW. Treatment failure due to extended spectrum [beta]-lactamase. J Antimicrob Chemother 1996;37:203-4.
2. Brun-Buisson C, Philippon A, Ansquer M, Legrand P, Montravers F, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during a nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987;2:302-6.
3. Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;23:118-24.
4. Venezia RA, Scarano FJ, Preston KE, et al. Molecular epidemiology of an SHV-5 extended-spectrum [beta]-lactamase in Enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin Infect Dis 1995;21:915-23.
5. Paterson DL, Ko W, Von Gottberg A, et al. In vitro susceptibility and clin-ical outcomes of bacteremia due to extended-spectrum [beta]-lactamase (ESBL)-producing Klebsiella pneumoniae [abstract]. Clin Infect Dis 1998;27:956.
6. Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996;38:409-24.
7. Tenover FC, Mohammed JM, Gorton T, Dembek ZF. Detection and reporting of extended-spectrum [beta]-lactamase (ESBL)-producing organisms in Connecticut [abstract]. Clin Infect Dis 1998;27:1064.
8. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
9. Katsanis GP, Spargo J, Ferraro MJ, Sutton L, Jacoby GA. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. J Clin Microbiol 1994;32:691-6.
10. Monnet DL, Biddle JW, Edwards JR, et al. Evidence of interhospital transmission of extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. Infect Control Hosp Epidemiol 1997;18:492-8.
11. D'Agata E, Venkataraman L, DeGirolami P, Weigel L, Samore M, Tenover F. The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum beta-lactamase in a tertiary care hospital. J Infect 1998;36:279-85.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 9th informational supplemented. Wayne, PA: National Committee for Clinical Laboratory Standards, 1999.
13. Lucet J-C, Decre D, Fichelle A, et al. Control of a prolonged outbreak of extended-spectrum [beta]-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis 1999;29:1411-8.
14. Bermudes H, Arpin C, Jude F, El-Harrif Z, Bebear C, Quentin C. Mole-cular epidemiology of an outbreak due to extended-spectrum beta-lactamase-producing enterobacteria in a French hospital. Eur J Clin Microbiol Infect Dis 1997;16:523-9.
15. Didier ME, Maki DG. Epidemiology of nosocomial infection caused by multi-resistant ESBL-producing Klebsiella [abstract P35]. Program and abstracts of the SHEA annual meeting (St Louis, MO). Mt Royal, NJ: Society for Healthcare Epidemiology of America, 1997.
16. French GL, Shannon KP, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and [beta]-lactam- [beta]-lactamase inhibitor combinations by hyperproduction of SHV-5 [beta]-lactamase. J Clin Microbiol 1996;34:358-63.
17. Gaillot O, Maruejouls C, Abachin E, et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol 1998;36:1357-60.
18. Gniadkoswki M, Palucha A, Grzesiowski P, Hryniewicz W. Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-50-like ESBL-encoding gene. Antimicrob Agents Chemother 1998;42:3079-85.
19. Gniadkoswki M, Schneider I, Jungwirth R, Hryniewicz W, Bauernfeind A. Ceftazidime-resistant enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended- spectrum beta-lactamases. Antimicrob Agents Chemother 1998;42:514-20.
20. Gniadkowski M, Schneider I, Palucha A, Jungwirth R, Mikiewicz B, Bauerfeind A. Cefotaxime-resistant enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother 1998;42:827-32.
21. Lhopital S, Bonacorsi S, Meis D, et al. Molecular markers for differentiation of multiresistant Klebsiella pneumoniae isolates in a pediatric hospital. Infect Control Hosp Epidemiol 1997;18:743-8.
22. Lucet J-C, Chevret S, Decre D, et al. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996;22:430-6.
23. Neuwirth C, Siebor E, Lopez J, Pechinot A, Kazmierczak A. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum [beta]-lactamase to other members of the family enterobacteriaceae. J Clin Microbiol 1996;34:76-9.
24. Palucha A, Mikiewicz B, Gniadkoswki M. Diversification of Escherichia coli expressing an SHV-type extended-spectrum beta-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1999;43:393-6.
25. Pena C, Pujol M, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended- spectrum beta-lactamases. Antimicrob Agents Chemother 1998;42:53-8.
26. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998;280:1233-7.
27. Yang Y, Bhachech N, Bradford P, Jett BD, Sahm DF, Bush K. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri. Anti-microb Agents Chemother 1998;42:1671-6.
28. Yagi T, Kurokawa H, Senda K, et al. Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like [beta]-lactamase genes. Antimicrob Agents Chemother 1997;41:2606-11.
29. Stewart BA, Lessing MPA. A hospital outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. J Hosp Infect 1999;41:71-8.
30. Sader HS, Pfaller MA, Jones RN. Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae. Diagn Microbiol Infect Dis 1994;20:203-8.
31. Eisen D, Russell EG, Tymms M, Roper EJ, Grayson ML, Turnidge J. Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol 1995;33:713-7.
32. Bingen EH, Desjardins P, Arlet G, et al. Molecular epidemiology of plasmid spread among extended broad-spectrum [beta]-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital. J Clin Microbiol 1993;31:179-84.
33. Gouby A, Neuwirth C, Bourg G, Bouziges N, Carles-Nurit MJ, Despaux E. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 1994;32:301-5.
34. Arlet G, Rouveau M, Casin I, Bouvet PJ, LaGrange PH, Philippon A. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 [beta]-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol 1994;32:2553-8.
35. Yuan M, Aucken H, Hall LMC, Pitt TL, Livermore DM. Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J Antimicrob Chemother 1998;41:527-39.
36. Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996;174:529-36.
37. Liu Y-FP, Tung JC, Ke SC, Chen SL. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan. J Clin Microbiol 1998;36:2759-62.
38. Prodinger WM, Fille M, Bauernfeind A, et al. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 1996;34:564-8.
39. Venezia RA, Scarano FJ, Preston KE, et al. Molecular epidemiology of an SHV-5 extended-spectrum [beta]-lactamase in Enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin Infect Dis 1995;21:915-23.
40. Morosini MI, Blazquez J, Negri MC, Canton R, Loza E, Baquero F. Characterization of a nosocomial outbreak involving an epidemic plasmid encoding for TEM-27 in Salmonella enterica subspecies enterica serotype Othmarschen. J Infect Dis 1996;174:1015-120.
41. Shannon K, Fung K, Stapleton P, Anthony R, Power E, French G. A hospital outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae investigated by RAPD typing and analysis of the genetics and mechanisms of resistance. J Hosp Infect 1998;39:291-300.
42. Weller TMA, MacKenzie FM, Forbes KJ. Molecular epidemiology of a large outbreak of multiresistant Klebsiella pneumoniae. J Med Microbiol 1997;46:921-6.
43. Decre D, Gachot B, Lucet JC, Arlet G, Bergogne-Berezin E, Regnier B. Clinical and bacteriologic epidemiology of extended-spectrum [beta]-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis 1998;27:834-44.
44. Coulter C, Faoagali JC, Doige S, Bodman J, George N. Hand culture surveillance to investigate transmission of epidemic extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a major intensive care unit [abstract]. Aust N Z J Med 1995;25:572.
45. Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect 1996;33:249-62.
46. Mebis J, Goossens H, Bruyneel P, et al. Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients. Leukemia 1998;12:1627-9.
47. Burke JP. Antibiotic resistance-squeezing the balloon? JAMA 1998;280:1270-1.
48. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997;41:563-9.
49. MacKenzie FM, Forbes KJ, Dorai-John T, Amyes SG, Gould IM. Emergence of a carbapenem-resistant Klebsiella pneumoniae [letter]. Lancet 1997;350:783.
50. Sterling TR, Ho EJ, Brehm WT, Kirkpatrick MB. Diagnosis and treatment of ventilator-associated pneumonia-impact on survival. Chest 1996;110:1025-34.
51. Bergmann DCJJ, Bonten MJM, Gaillard CA, et al. Indications for antibiotic use in ICU patients: a one year prospective surveillance. J Antimicrob Chemother 1997;39:527-35.
52. Singh N, Rogers P, Atwood C, Yu VL. Short course empiric antibiotic therapy for suspected nosocomial pneumonia: a proposed solution for indiscriminate antibiotic prescription for pulmonary infiltrates in the ICU [abstract]. Clin Infect Dis 1998;27:936.
|
Language: | English.
|
Document Type: | Clinical Articles.
|
Journal Subset: | Clinical Medicine. Life & Biomedical Sciences.
|
ISSN: | 1058-4838
|
DOI Number: | https://dx.doi.org/10.1086/31355...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|